Certain serologic and clinical features can help predict a chronic disease course among children with juvenile idiopathic inflammatory myopathies (JIIM), a large registry study showed.
Biosimilars are in the news and will be prominently on parade at next week's ACR meeting in San Francisco. Biosimilars are similar to, but not the same as, innovator biologics.
JAMA reports the results of trends in drug use in the USA over a 13 year period using data derived 37959 adults survey in the National Health and Nutrition Examination Survey (NHANES). An overall increase in the use of prescription drugs was seen among US adults between 1999-2000 and 2011-2012.
A retrospective population-based study from New Zealand examined the epidemiology, clinical features, and microbiology of adult native joint septic arthritis. Specifically, they studied the populatoin of Canterbury, New Zealand over a 5-year period - looking at individuals with and without an underlying rheumatic disorder.
To assess the prevalence and magnitude of healthcare costs associated with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in the USA, researchers analyzed adminstrative data from Truven Health MarketScan Commercial and Medicare Supplemental databases. Major relapses (using the Birmingham Vasculitis Activity Score) and healthcare costs were assessed during a 24-month followup period.
In October 2015, RheumNow published 76 tweets about impactful news, research and teaching points that impact the rheumatology community. In October, RN had a reach (impressions) of 49,500, 79 mentions, and over 2000 visits to RheumNow.com to check out what we publish. The average daily “tweet” from RheumNow is seen by 3000-8,000 viewers.
Off-label use of prescription drugs was associated with adverse drug events in a study of patients in Canada, according to an article published online by JAMA Internal Medicine.
Using Medicare claims data, a retrospective cohort study analyzed the risk of a second non-melanomatous skin cancer (NMSC) in 9460 individuals (6841 with RA and 2788 with IBD).
The overall incidence rate of a second NMSC was roughly the same for RA and IBD patients, 58.2 per 1000 person-years and 58.9/1000PY in IBD, respectively.
Each month, RheumNow reviews compiled listings of drug shortages germane to the practive of rheumatology using several sources. If you have suggestions or information about specific drug shortages or drug safety issues please email us at info@rheumnow.com.
Our primary sources of information include: Drugs.com, the FDA and the University of Utah pharmacy (see table below).
A Danish cohort study examined patients with hyperuricemia and compared outcomes in those proven to have urate crystal deposition (317 patients) and matched 1:1 to patients without urate crystals. Interestingly, of the 80,726, 79,629 did not have uric acid crystal identification.
MONTREAL -- An immunosuppressive drug was as effective as a standard agent for interstitial lung disease (ILD) associated with scleroderma, a researcher said.
But mycophenolate (CellCept)was better tolerated than the old standby, the oral alkylating agent cyclophosphamide, according to Donald Tashkin, MD, of the David Geffen School of Medicine at the University of California Los Angeles.
A team of Japanese investigators examine 126 patients with ANCA-associated renal vasculitis to see if ANCA levels would predict disease relapse.
Using death certificate data from US National Vital Statistics System of the National Center for Health Statistics (NCHS) and the Centers for Disease Control and Prevention, JAMA reports a downward trend in death rates in the USA from 1969 - 2013).
Are you efficient, productive and accurate in what you do? Could you be better? Or do the job differently?
The October 27 issue of JAMA reports a study of federal marketplace insurance plans shows roughly 15 percent completely lacked in-network physicians for at least one specialty, a practice found among multiple states and issuers.
